ViCentra Announces Commercial Launch of New Smartphone-Controlled Kaleido Automated Insulin Delivery Patc
3 Articles
3 Articles
ViCentra Announces Commercial Launch of New Smartphone-Controlled Kaleido Automated Insulin Delivery Patc
New system combines Kaleido with Diabeloop's DBLG2 algorithm and Dexcom G7, with first commercial deliveries in Germany and the Netherlands planned for later this summer Enables insulin automation to be controlled directly from the user's smartphone, rather than a separate dedicated handset Starting on Kaleido today with Diabeloop's DBLG1 algorithm is the fastest path to Kaleido with DBLG2 and Dexcom G7 UTRECHT, The Netherlands, May 12, 2026 (GL…
ViCentra Announces Commercial Launch of New Smartphone-Controlled Kaleido Automated Insulin Delivery Patch Pump System
New system combines Kaleido with Diabeloop’s DBLG2 algorithm and Dexcom G7, with first commercial deliveries in Germany and the Netherlands planned for later this summer Enables insulin automation to be controlled directly from the user’s smartphone, rather than a separate dedicated handset Starting on Kaleido today with Diabeloop’s DBLG1 algorithm is the fastest path to […] The post ViCentra Announces Commercial Launch of New Smartphone-Control…
Diabeloop gets CE mark for new AID algorithm with Dexcom G7
Diabeloop announced today that it received CE mark approval for its latest automated insulin delivery (AID) platform, DBLG2. CE mark approval comes not long after FDA approval in December 2025. The algorithm initially received CE mark last year but now has European approval for compatibility with next-generation devices. With clearance for DBLG2, integrated with the Dexcom G7 continuous glucose monitor (CGM), the company has kicked off the gradu…
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
